With an Expected Decline to Low Single Digit Growth across Various Reporter Gene Assay Segments, Luciferase Assay Demand Remains Strong
Carlsbad, Calif. – August 30, 2013: Percepta Associates announces the launch of its Reporter Gene Assays Life Science Dashboard™ market research report revealing Life Technologies (including Invitrogen brand), Promega, Sigma Aldrich, Clontech, Thermo Fisher (including Pierce brand), Roche Applied Sciences and Invivogen as leading suppliers across various segments. Market segments analyzed in this report include: beta-galactosidase (LacZ) assays, chloramphenicol acetyltransferase (CAT) assays, fluorescent protein related assays, e.g. GFP, YFP, etc., luciferase assays and other reporter gene assays, e.g. beta-glucuronidase (GUS), secreted alkaline phosphatase (SEAP), human growth hormone (HGH) reporter assays, beta-lactamase, etc.
With a significant percentage of high volume users, highest projected growth and highest monthly spend per laboratory the luciferase assay market is attractive with reasonable potential for additional growth. “Though some researchers indicate their projects have ended or are winding down, the number of researchers projecting growth in luciferase assays outnumber decliners by 2:1”, said Sarab Khandpur, Associate Consultant and Editor of the Life Science Dashboard™ publications. “This 2013 Reporter Gene Assays Life Science DashboardTM report provides a detailed analysis of end user practices and preferences for luciferase and other key reporter gene assay research segments.”
Designed and executed by individuals with practical industry experience, this report contains strategically grounded findings and recommendations that can simplify business planning and guide you in a more competitive direction with confidence and certainty.
Findings are based on survey responses obtained from 433 academic and commercial research scientists in North America and Europe from our leading proprietary panel of active life scientists. Key market indicators detailed in the report include:
- Overall and segment market sizes & market growth rates
- Share of mentions
- Reaction throughput rates
- Customer satisfaction & propensity to switch suppliers
- Competitive landscape*
- Perceived pricing/monthly spend
- Assay usage frequency
- Research focus and target of reporter gene assays
- Purchase decision factors
- Desired product changes
*Companies cited by respondents in this report include:
- EMD Millipore
- GE Healthcare Life Sciences
- Gold Biotechnology
- Life Technologies/Invitrogen
- Perkin Elmer
- Roche Applied Sciences
- Sigma Aldrich
- Switchgear Genomics
- Thermo Fisher Scientific/Pierce
Founded in 2005 in Carlsbad, California Percepta is a specialized consultancy providing market assessment, product development and pricing, brand assessment and development, market planning, ad concept and message testing and due diligence services to life science research suppliers globally. For more information visit: www.perceptaassociates.com or call 877 597 9236.
Percepta Associates Inc.
Assoc. Consultant/Editor – Life Science Dashboard™
Phone: 877 597 9236